No Data
No Data
ORIC Pharmaceuticals to Participate in Upcoming Investor Conferences
Express News | Oric® Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Wells Fargo Initiates Oric Pharmaceuticals(ORIC.US) With Buy Rating, Announces Target Price $20
Oric Pharmaceuticals Initiated at Buy by Jones Trading
Express News | Oric Pharmaceuticals, Inc. : Wells Fargo Initiates Coverage With Overweight Rating and Target Price $20
JonesTrading Initiates Oric Pharmaceuticals(ORIC.US) With Buy Rating, Announces Target Price $17
loading...